Desideri G - Search Results

1

Neuroprotective potential of choline alfoscerate against β-amyloid injury: Involvement of neurotrophic signals.

Catanesi M, d'Angelo M, Antonosante A, Castelli V, Alfonsetti M, Benedetti E, Desideri G, Ferri C, Cimini A. Catanesi M, et al. Among authors: desideri g. Cell Biol Int. 2020 Aug;44(8):1734-1744. doi: 10.1002/cbin.11369. Epub 2020 May 6. Cell Biol Int. 2020. PMID: 32343461

2

Impaired inactive to active kallikrein conversion in human salt-sensitive hypertension.

Bellini C, Ferri C, Carlomagno A, Necozione S, Lepore AR, Desideri G, Santucci A. Bellini C, et al. Among authors: desideri g. J Am Soc Nephrol. 1996 Dec;7(12):2565-77. doi: 10.1681/ASN.V7122565. J Am Soc Nephrol. 1996. PMID: 8989735 Clinical Trial.

3

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo.

Pastore L, Tessitore A, Martinotti S, Toniato E, Alesse E, Bravi MC, Ferri C, Desideri G, Gulino A, Santucci A. Pastore L, et al. Among authors: desideri g. Circulation. 1999 Oct 12;100(15):1646-52. doi: 10.1161/01.cir.100.15.1646. Circulation. 1999. PMID: 10517737

4

Circulating vascular endothelial growth factor levels are decreased in patients with chronic hepatitis and liver cirrhosis depending on the degree of hepatic damage.

Desideri G, Ferri C. Desideri G, et al. Clin Sci (Lond). 2000 Aug;99(2):159-60. Clin Sci (Lond). 2000. PMID: 10918050 No abstract available.

5

Endothelial activation in patients with cardiac syndrome X.

Desideri G, Gaspardone A, Gentile M, Santucci A, Gioffrè PA, Ferri C. Desideri G, et al. Circulation. 2000 Nov 7;102(19):2359-64. doi: 10.1161/01.cir.102.19.2359. Circulation. 2000. PMID: 11067789

6

Patterns of myocardial endothelin-1 expression and outcome after cardiac transplantation.

Ferri C, Properzi G, Tomassoni G, Santucci A, Desideri G, Giuliani AE, Starling RC, Ratliff NB, Cook DJ, McCarthy P, Young JB, Yamani MH. Ferri C, et al. Among authors: desideri g. Circulation. 2002 Apr 16;105(15):1768-71. doi: 10.1161/01.cir.0000015606.69079.27. Circulation. 2002. PMID: 11956116

7

Prolonged, low dose alpha-tocopherol therapy counteracts intercellular cell adhesion molecule-1 activation.

Desideri G, Croce G, Marinucci MC, Masci PG, Stati M, Valeri L, Santucci A, Ferri C. Desideri G, et al. Clin Chim Acta. 2002 Jun;320(1-2):5-9. doi: 10.1016/s0009-8981(02)00041-4. Clin Chim Acta. 2002. PMID: 11983194 Clinical Trial.

8

Vitamin E supplementation reduces plasma vascular cell adhesion molecule-1 and von Willebrand factor levels and increases nitric oxide concentrations in hypercholesterolemic patients.

Desideri G, Marinucci MC, Tomassoni G, Masci PG, Santucci A, Ferri C. Desideri G, et al. J Clin Endocrinol Metab. 2002 Jun;87(6):2940-5. doi: 10.1210/jcem.87.6.8545. J Clin Endocrinol Metab. 2002. PMID: 12050277 Clinical Trial.

9

L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.

Cassone Faldetta M, Laurenti O, Desideri G, Bravi MC, De Luca O, Marinucci MC, De Mattia G, Ferri C. Cassone Faldetta M, et al. Among authors: desideri g. Diabetologia. 2002 Aug;45(8):1120-7. doi: 10.1007/s00125-002-0854-1. Epub 2002 Jun 22. Diabetologia. 2002. PMID: 12189442 Clinical Trial.

10

Effects of obesity and weight loss on soluble CD40L levels.

Desideri G, Ferri C. Desideri G, et al. JAMA. 2003 Apr 9;289(14):1781-2. doi: 10.1001/jama.289.14.1781. JAMA. 2003. PMID: 12684355 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page